Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of DLBS2411 on Gastric pH Regulation
NCT01573403Phase 2Completed
- Sponsor
- Dexa Medica
- Start
- Apr 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DLBS2411 in gastroesophageal reflux disease (GERD), sponsored by Dexa Medica. Started Apr 2012; status: completed.
02
Drugs
DLBS2411
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01573403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01573403.